Skip to main content

Table 2 Utilisation of statins, acute myocardial infarction (AMI)-mortality, AMI-incidence and coronary revascularisation rates in Sweden's 289 municipalities' female populations, 1998-2002.

From: No connection between the level of exposition to statins in the population and the incidence/mortality of acute myocardial infarction: An ecological study based on Sweden's municipalities

  Utilisation of statins DDD/TID1
Age/years 1998 1999 2000 2001 2002
40-49 4.98 (0.27-18.7) 6.68 (0.2-32.7) 9.22 (0.13-41.3) 11.2 (0.82-46.4) 13.1 (0.88-38.2)
50-59 19.6 (2.14-59.9) 28.2 (6.45-86.8) 40.3 (11.0-135) 50.6 (15.6-207) 61.5 (20.8-221)
60-69 49.8 (7.52-120) 69.8 (10.7-162) 96.2 (18.1-206) 119 (40.7-251) 141 (45.3-288)
70-79 45.7 (3.05-128) 67.1 (17.4-178) 97.8 (30.9-250) 131 (40.3-315) 165 (56.2-354)
  AMI-Mortality/1000 1
Age/years 1998 1999 2000 2001 2002
40-49 0.06 (0-2.56) 0.06 (0-2.36) 0.07 (0-2.60) 0.05 (0-2.56) 0.04 (0-3.36)
50-59 0.15 (0-2.02) 0.17 (0-4.59) 0.22 (0-2.69) 0.21 (0-4.07) 0.19 (0-3.02)
60-69 0.86 (0-8.06) 1.00 (0-7.16) 0.91 (0-7.16) 0.87 (0-7.17 0.75 (0-8.33)
70-79 3.96 (0-15.3) 3.92 (0-17.2) 3.46 (0-13.9) 2.98 (0-13.7) 3.00 (0-20.0)
  AMI-Incidence/1000 1
Age/years 1998 1999 2000 2001 2002
40-49 0.45 (0-4.75) 0.46 (0-4.14) 0.41 (0-4.72) 0.46 (0-7.47) 0.42 (0-5.35)
50-59 1.28 (0-10.9) 1.48 (0-5.74) 1.46 (0-8.45) 1.57 (0-11.1) 1.53 (0-6.37)
60-69 4.28 (0-15.4) 4.36 (0-18.0) 4.19 (0-15.7) 4.51 (0-31.7) 4.49 (0-14.9)
70-79 13.1 (0-33.5) 12.8 (0-33.4) 12.6 (0-47.4) 13.0 (0-31.2) 12.8 (0-35.2)
  Coronary-Revascularisation/1000 1
Age/years 1998 1999 2000 2001 2002
40-49 0.32 (0-3.36) 0.28 (0-4.14) 0.32 (0-2.14) 0.34 (0-3.30) 0.42 (0-5.35)
50-59 0.95 (0-5.88) 1.13 (0-6.56) 1.24 (0-8.45) 1.28 (0-7.85) 1.25 (0-8.06)
60-69 2.49 (0-11.9) 2.42 (0-15.7) 2.66 (0-12.2) 3.08 (0-13.6) 3.18 (0-11.3)
70-79 3.28 (0-17.2) 3.24 (0-13.1) 3.87 (0-19.1) 3.95 (0-31.9) 4.60 (0-17.4)
  1. Utilisation of statins expressed as Defined Daily Doses per 1000 Inhabitants and Day (DDD/TID).
  2. 1 Mean (range)